The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
ALEXANDRIA, Va - "ASCO is pleased that the FDA has issued new rules that strike a balance between meeting the immediate needs of seriously ill cancer patients today, while safeguarding the clinical trials system so it can develop new drugs to treat cancer patients in the future.
The new rules will make it clearer for doctors and patients to access experimental drugs when other treatment options have been exhausted and clinical trials are not available.
ASCO will be developing tools to ensure that oncologists understand the new rules and can help their patients benefit.”
